AstraZeneca PLC
1323.50
24-April-25 03:41:16
15 minutes delayed
Stocks
-2.50
-0.19%
Today's range
1319.50 - 1330.00
ISIN
N/A
Source
Cboe
-
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
25 Apr 2024 11:52:49 By NASDAQ US Markets
-
25 Apr 2024 10:30:48 By NASDAQ US Markets
-
25 Apr 2024 10:15:48 By NASDAQ Stocks
-
AstraZeneca Q1 Profit, Revenues Climb; Backs FY24 Outlook
25 Apr 2024 02:16:35 By NASDAQ US Markets
-
ANGLE Reaches Deal With AstraZeneca To Advance DDR Assay For Circulating Tumor Cell Detection
24 Apr 2024 02:37:17 By NASDAQ US Markets
-
FDA Approves AstraZeneca And Daiichi Sankyo's Enhertu For Solid Tumors Treatment
05 Apr 2024 21:16:14 By NASDAQ US Markets
-
Pharma Stock Roundup: AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase III
05 Apr 2024 08:38:12 By NASDAQ Stocks
-
AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod
02 Apr 2024 09:15:53 By NASDAQ Stocks
-
Next-Gen Cancer Therapies Could Spark Upside for AstraZeneca Stock
26 Mar 2024 17:07:03 By NASDAQ Stocks
-
AstraZeneca Announces FDA Approval For Ultomiris - Quick Facts
25 Mar 2024 02:55:20 By NASDAQ US Markets
-
Fusion (FUSN) Up 99% on $2.4B Buyout Offer From AstraZeneca
20 Mar 2024 13:32:29 By NASDAQ Stocks
-
AstraZeneca To Buy Fusion Pharma For Up To $2.4 Bln
19 Mar 2024 02:31:51 By NASDAQ US Markets
-
AstraZeneca To Expand Savings Programs For US Inhaled Respiratory Portfolio
18 Mar 2024 06:40:23 By NASDAQ US Markets
-
First Week of AZN May 17th Options Trading
15 Mar 2024 11:39:15 By NASDAQ Stocks
-
AstraZeneca To Buy Amolyt Pharma For Up To $1.05 Bln To Expand Late-stage Rare Disease Pipeline
14 Mar 2024 02:46:14 By NASDAQ US Markets
-
AstraZeneca Announces Initiation Of Phase III Trial With BREZTRI
13 Mar 2024 06:41:44 By NASDAQ US Markets
-
AZN Crosses Above Key Moving Average Level
11 Mar 2024 15:51:21 By NASDAQ US Markets
-
AZN Crosses Above Key Moving Average Level
11 Mar 2024 15:44:19 By NASDAQ Stocks
-
AstraZeneca's Datopotamab Deruxtecan Applications Validated In EU For Lung Cancer, Breast Cancer
04 Mar 2024 02:26:38 By NASDAQ US Markets
-
AstraZeneca: Voydeya Recommended For Approval In The EU By CHMP - Quick Facts
26 Feb 2024 01:56:02 By NASDAQ US Markets